|
⚲
|
| Keyboard |
| Margarita Chavez | |
|---|---|
| Firm | |
| Address | c/o Aligos Therapeutics, Inc One Corporate Dr, 2nd Floor South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aligos Therapeutics Inc | 021-539576 | Director | 105.0 M of 105.0 M |
||
| SNC Therapeutics Inc | 021-475270 | Director | 0.2 M of 5.0 M |
||
| Ambagon Therapeutics Inc | 021-429995 | Director | 45.0 M of 85.0 M |
||
| Carisma Therapeutics Inc | 021-385203 | Director | 38.3 M of 70.4 M |
||
| Ambagon Therapeutics Inc | 021-372342 | Director | 5.4 M of 5.4 M |
||
| Magnolia Neurosciences Corp | 021-371555 | Director | 18.4 M of 18.4 M |
||
| Nitrome Biosciences Inc | 021-365579 | Director | 17.1 M of 47.5 M |
||
| Rodeo Therapeutics Corp | 021-327473 | Director | 8.9 M of 8.9 M |
||
| Magnolia Neurosciences Corp | 021-319505 | Director | 8.0 M of 13.1 M |
||
| Carisma Therapeutics Inc | 021-316355 | Director | 52.9 M of 52.9 M |
||
| Carma Therapeutics Inc | 021-288759 | Director | 3.9 M of 3.9 M |
||